반응형
구분 | 보고서(영문) |
제약/바이오/ 임상시험(6건) |
Self-Sampling for HPV Improves Screening Rates in Non-attendees by 12% |
Scholar Rock’s Apitegromab Shows Promise for Non-Ambulatory SMA Patients | |
Top 20 Biopharmas’ Market Cap Up 4.3% in Q2 2024 as GLP-1 Drug Innovators Hold Top Spots | |
Shortages Improve for Lilly’s GLP-1 Weight Loss Drugs, Bumping Sales Forecast by $3 Billion | |
Colombia’s President Signs Law to Strengthen Pharmaceutical Sector | |
Licensing agreements for innovator GLP1R drugs weigh in with over $6.2 billion in 2024 | |
컨퍼런스/ 심포지엄/ 학회/기타 (3건) |
England and Wales Disparity in Pregnant Women’s COVID-19 and Influenza Vaccine Uptake |
Nationwide Danish Atrial Fibrillation Study Finds Diminishing Sex Differences in Stroke Outcomes | |
Discrepancies Among Guidelines for Opioid Use in Chronic Pain Could Compound Addiction | |
질환별 (8건) |
Migraine: Seven-Market Drug Forecast and Market Analysis |
Acute Coronary Syndrome: Competitive Landscape | |
Global Mpox Emergency Raises Questions on How to Avoid Another UK Outbreak | |
Epstein-Barr Virus: Competitive Landscape | |
Focal Segmental Glomerulosclerosis: Competitive Landscape | |
Celiac Disease: Competitive Landscape | |
First Real-World Data for rVSV-ZEBOV Vaccine Supports Use for Future Ebola Outbreaks | |
Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033 |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 9.13. (금) (0) | 2024.09.15 |
---|---|
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.14. (수) (0) | 2024.09.15 |
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 7.5. (금) (0) | 2024.09.15 |
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목) (0) | 2024.09.15 |
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수) (0) | 2024.09.15 |